Levotuss Tosse (Levodropropizine)

Levodropropizine acts on sensory C‑fibers in the respiratory tract, blocking the transmission of irritation signals to the brainstem cough centre. By inhibiting these peripheral pathways, it lowers cough reflex sensitivity without depressing the central nervous system.

The appropriate dose of Levotuss Tosse is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and local prescribing guidelines. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for levodropropizine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Levotuss Tosse.

To order Levotuss Tosse, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Unlike centrally acting antitussives such as codeine, levodropropizine works peripherally, offering cough relief without the risk of sedation or dependence. This makes it a suitable alternative for patients who need cough control but must avoid central nervous system effects.

Levotuss Tosse should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Levotuss Tosse is administered orally. The exact dosage form (tablet, syrup, etc.) is defined by the manufacturer, and patients should take the medication exactly as prescribed, typically with or without food as directed by their healthcare professional.

Serious but rare risks include allergic reactions such as rash, pruritus, angioedema, or anaphylaxis, as well as hepatic dysfunction indicated by elevated liver enzymes. Patients experiencing any signs of severe hypersensitivity or liver injury should seek immediate medical attention.

Levotuss Tosse is contraindicated in individuals with known hypersensitivity to levodropropizine or any excipients in the formulation. Patients with severe hepatic impairment or those taking prohibited concomitant medications should avoid use unless specifically advised by a physician.